Results 231 to 240 of about 1,349,844 (305)

Response to letter regarding associations of dietary indices with risk of all-cause and cardiovascular mortality in hypertensive adults. [PDF]

Ann Med
Chen F.
europepmc   +1 more source

Physical Fitness Profiles Among Children and Adolescents With ADHD and ASD: A Comparison With Typically Developing Peers

Autism Research, EarlyView.
ABSTRACT Children and adolescents with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) often present physical and motor challenges that may compromise health, yet direct comparisons between these neurodevelopmental conditions and typically developing (TD) peers remain limited.
Nerea Blanco‐Martínez, Rocío Carballo‐Afonso, Joel Estévez‐Agudo, Carlos Ayán‐Pérez, José Carlos Diz‐Gómez   +4 more
wiley   +1 more source

Lymphocyte-To-Monocyte Ratio is Partially Mediated in Age-Related Cardiovascular Mortality in HFpEF: Immunosenescence, Inflamm-Aging, and Longevity. [PDF]

Rev Cardiovasc Med
Cai X, Liu M, Feng C, Tang S, Qin P, Li Y, Wang T, He L, Lei J, Zhou Y, Guo Y, Zhuang X, Liao X.   +12 more
europepmc   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Systemic immune-inflammatory index predicts all-cause and cardiovascular mortality in metabolic syndrome: A prospective cohort study using NHANES data. [PDF]

Clinics (Sao Paulo)
Sun Y, Yang S, Xiao Z, An Y, Zhao H.
europepmc   +1 more source

Mortality from Cardiovascular Disease

Sangyo Igaku, 1967
H. Kato, K. G. Johnson, K. Yano
openaire   +2 more sources

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

The U-shaped correlation between the systemic immune-inflammation index and all-cause and cardiovascular mortality in hyperlipidemic patients: findings from NHANES 1999-2018. [PDF]

Ann Med
Ma D, Zhou Q, Yu J, Xu C, Yang L, Ning L.   +5 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Association of albumin-corrected anion gap with all-cause and cardiovascular mortality in overactive bladder patients. [PDF]

Sci Rep
Lin S, Chen X.
europepmc   +1 more source